Sun Pharma Advanced Research Co LtdSun Pharma Advanced Research Co Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Check the bottom of this webpage for potential risks for Sun Pharma Advanced Research Co Ltd based on sector, location and marketcap. The ESG score for Sun Pharma Advanced Research Co Ltd represents the company's reporting of the United Nations SDGs. This report of Sun Pharma Advanced Research Co Ltd employs data points from across the web as well as from available disclosures by Sun Pharma Advanced Research Co Ltd.

Sun Pharma Advanced Research Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.5; made up of an environmental score of 6.4, social score of 8.0 and governance score of 8.0.

SDG Transparency Score for Sun Pharma Advanced Research Co Ltd 
Low
0 - 3
Medium
4 - 6

7.5

High Impact
7 - 10
Last Score Update: 2023-07-01
What drives the score for Sun Pharma Advanced Research Co Ltd 
6.4

Environmental

8.0

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
209WuXi AppTec Co Ltd
7.6
High
209Waters Corp
7.6
High
256Sun Pharma Advanced Research Co Ltd
7.5
High
256Acorda Therapeutics Inc
7.5
High
256Alkermes Plc
7.5
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Sun Pharma Advanced Research Co Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd offer flexible work?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd disclose water use targets?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Sun Pharma Advanced Research Co Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Sun Pharma Advanced Research Co Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Sun Pharma Advanced Research Co Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd disclose its waste policy?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd disclose energy use targets?

LockedSign up for free to unlock

Does Sun Pharma Advanced Research Co Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Sun Pharma Advanced Research Co Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Sun Pharma Advanced Research Co Ltd
These potential risks are based on the size, segment and geographies of the company.

Sun Pharma Advanced Research Company Limited, a biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops new chemical and biological entities, and reformulated products with a therapeutic focus on oncology, neurodegeneration, ophthalmology, dermatology, and Immunology. The company offers Elepsia, a formulation of levetiracetam that is an anti-epileptic agent to treat epilepsy disorder; and Xelpros, a latanoprost ophthalmic emulsion for the treatment of open-angle glaucoma or ocular hypertension. In addition, it is developing SDN-037, a formulation of difluprednate for the treatment of inflammation and pain associated with ocular surgery that is in phase 3 clinical trial; PDP-716 to treat glaucoma, which is in phase 3 clinical trial; phenobarbital sodium for the treatment of neonatal seizures; Vodobatinib (SCO-088) for the treatment of resistant chronic myelogenous leukemia that has completed a part A of the Phase 1 study; Vodobatinib (SCC-138), which is in phase 2 clinical trial to treat Parkinson's disease; SCD-044 for the treatment of psoriasis and atopic dermatitis that is in phase 2 clinical trial; and SCO-120 for the treatment of hormone receptor-positive, human epidermal receptor 2 negative, and metastatic breast cancer, which is in phase 1 clinical trial. Sun Pharma Advanced Research Company Limited has a collaboration agreement with Bioprojet to develop an S1P receptor 1 agonist for autoimmune disorders. The company was incorporated in 2006 and is based in Mumbai, India. Sun Pharma Advanced Research Company Limited is a subsidiary of Shanghvi Finance Private Limited.

Sorry!

Failed to process!